Actavis announced that it has received final FDA approval for its Abbreviated New Drug Application (ANDA) of Clonidine Transdermal System, the generic version of Boehringer Ingelheim's Catapres-TTS.

If Actavis were allowed to discontinue sales of an older Alzheimer’s pill and steer patients toward a newer version in order to blunt generic competition, the move could cost Medicare Part D as ...

Actavis is nearing a deal to acquire Allergan in a tie-up that would likely be the year’s largest and could help shield the Botox maker from hostile suitor Valeant.

A federal judge ruled on Thursday that pharmaceutical company Actavis has to keep selling an Alzheimer's drug it had intended to stop producing. The order stems from a lawsuit filed by New York ...

Actavis, which maintains U.S. headquarters in New Jersey, sells generic and branded drugs in more than 60 countries. As of December 2013, the company employed 19,200 people around the world.

As Actavis' incoming chief executive, Saunders said he and the company plan to stick around, even as the drug industry experiences one of the busiest deals environments in history.

Hedge fund mogul Bill Ackman has nothing but good words for Actavis CEO Brenton Saunders, the man who bested him in the battle for botox maker Allergan. But while the words are kind, Ackman is not … ...

A Delaware federal court found in 2020 that Actavis' proposed generic of Quillivant XR infringed the patents. The U.S. Court of Appeals for the Federal Circuit affirmed, opens new tab the Delaware ...

The deal calls for Actavis to pay $26.04 in cash and 0.3306 shares for each share of Forest common stock. That translates to a price tag of $89.48, representing a 25% premium on Forest’s closing ...

Iceland's Actavis Group <ACT.IC> has agreed to acquire U.S.-based specialty generics drugmaker Abrika Pharmaceuticals for up to $235 million, it said on Thursday.